The trajectory of Viagra presents a interesting case for investors in the drug sector. While initially a tremendous success, producing huge profits, the patent lapse and the subsequent flood of generic alternatives have drastically changed revenue. This poses questions about the future profitability of related medication projects and suggests th… Read More